Bundred, N. J., Morrison, J. M., Ratcliffe, W. A., Ratcliffe, J. G., Warwick, Jane and Walker, R. A. (1992) Parathyroid hormone related protein and skeletal morbidity in breast cancer. European Journal of Cancer Care, Volume 28 (Number 2-3). pp. 690-692. doi:10.1016/S0959-8049(05)80127-3

Clarke, M., Gray, R., Dunn, Janet A. and Maclennan, I. (1992) Combination chemotherapy for myelomatosis. The Lancet, 340 (8816). p. 433. doi:10.1016/0140-6736(92)91520-I

Dunn, Janet A. (1992) Prognostic indices : who needs them? Controlled Clinical Trials, 13 (5). pp. 381-382. doi:10.1016/0197-2456(92)90053-3

Dunn, Janet A. and Hallissey, M. T. (1992) Developing a prognostic index for stomach cancer. Controlled Clinical Trials, 13 (5). p. 427. doi:10.1016/0197-2456(92)90163-T

Dunn, Janet A. and MacLennan, I. (1992) Comparing trials for the treatment of myelomatosis. Controlled Clinical Trials, 13 (5). p. 441. doi:10.1016/0197-2456(92)90198-9

Finn, C. B., Luesley, D. M., Buxton, E. J., Blackledge, G. R., Kelly, K., Dunn, Janet A. and Wilson, S. (1992) Is stage I epithelial ovarian cancer over-treated both surgically and systematically? Results of a five-year cancer registry review. Obstetrical and Gynecological Survey, 47 (7). pp. 491-493. doi:10.1016/0197-2456(92)90198-9

Finn, Catherine B., Luesley, D. M., Buxton, E. J., Blackledge, G. R., Kelly, K., Dunn, Janet A. and Wilson, S. (1992) Is Stage I epithelial ovarian cancer overtreated both surgically and systemically? Results of a five-year cancer registry review. BJOG: An International Journal of Obstetrics and Gynaecology, 99 (1). pp. 54-58. doi:10.1111/j.1471-0528.1992.tb14393.x

Lynch, T. H., Waymont, B., Dunn, Janet A. and Wallace, D. M. A. (1992) Urologists' attitudes to the management of bladder cancer. British Journal of Urology, 70 (5). pp. 522-525. doi:10.1111/bju.1992.70.5.522

The Medical Research Council Working Party For Leukæmia In Adults (Including: MacLennan, I. C. M., Chapman, C., Dunn, Janet A. and Kelly, K.). (1992) Combined chemotherapy with ABCM versus melphalan for treatment of myelomatosis. The Lancet, 339 (8787). pp. 200-205. doi:10.1016/0140-6736(92)90004-M

Oláh, K. S., Dunn, Janet A. and Gee, H. (1992) Leiomyosarcomas have a poorer prognosis than mixed mesodermal tumours when adjusting for known prognostic factors : the result of a retrospective study of 423 cases of uterine sarcoma. BJOG: An International Journal of Obstetrics & Gynaecology, 99 (7). pp. 590-594. doi:10.1111/j.1471-0528.1992.tb13827.x

Ward, L. C., Fielding, J. W. L. and Dunn, Janet A. (1992) The selection of cases for randomised trials : a registry survey of concurrent trial and non-trial patients. British Journal of Cancer, 66 (5). pp. 943-950. doi:10.1038/bjc.1992.390

Waymont, B., Lynch, T. H., Dunn, Janet A., Emtage, L. A., Arkell, D. G., Wallace, D. M. A. and Blackledge, G. R. P. (1992) Phase III randomised study of Zoladex versus Stilboestrol in the treatment of advanced prostate cancer. British Journal of Urology, 69 (6). pp. 614-620. doi:10.1111/j.1464-410X.1992.tb15633.x